Literature DB >> 3942300

Cardiac dysrhythmias induced by infusion of local anesthetics into the lateral cerebral ventricle of cats.

J E Heavner.   

Abstract

The hypothesis that neurogenically mediated cardiac arrhythmias can be induced by the intracerebroventrical (ICV) infusion of local anesthetic solutions was tested in 11 chronically prepared, unmedicated cats. Test substances were bupivacaine (0.1%), lidocaine (0.4%), procaine (0.4 or 0.8%), or saline (pH 5.8). Cats received one or more of the test substances with two or more days between infusions. Four cats were also given bupivacaine intravenously at 1.1 and 1.4 mg/kg to help determine whether ECG changes after ICV injection of local anesthetic were due to direct cardiac action after systemic absorption. Total dose was 3.8-7.8 X the largest ICV dose (0.7 mg). No ventricular arrhythmias were observed after the ICV infusion of saline or with intravenous doses of bupivacaine as large as 1.4 mg/kg. Only one of six cats given lidocaine ICV developed sustained, severe ventricular arrhythmias. Five of seven cats given ICV procaine developed ventricular arrhythmias. All ten cats given ICV bupivacaine developed ventricular arrhythmias. It is concluded that local anesthetics can produce neurogenically mediated ventricular arrhythmias in cats and that, of the three local anesthetics tested, bupivacaine is the most potent and effective and lidocaine is the least potent and effective.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942300

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  [Toxicology of local anesthetics. Clinical, therapeutic and pathological mechanisms].

Authors:  W Zink; B M Graf
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

Review 2.  Local anesthetics.

Authors:  J A Yagiela
Journal:  Anesth Prog       Date:  1991 Jul-Oct

3.  Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep.

Authors:  D H Chang; L A Ladd; S Copeland; M A Iglesias; J L Plummer; L E Mather
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

4.  Effects of bupivacaine and lidocaine on cardiac function in awake and pentobarbital-anesthetized rats.

Authors:  Satoshi Kashimoto; Marie-Françoise Doursout; Patrick Wouters; Takeshi Oguchi
Journal:  J Anesth       Date:  1997-03       Impact factor: 2.078

5.  Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model.

Authors:  Kevin Baranger; Manuel van Gijsel-Bonnello; Delphine Stephan; Wassila Carpentier; Santiago Rivera; Michel Khrestchatisky; Bouchra Gharib; Max De Reggi; Philippe Benech
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

6.  Effects of ropivacaine and bupivacaine on rabbit myocardial energetic metabolism and mitochondria oxidation.

Authors:  Shihai Zhang; Shanglong Yao; Qing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

7.  Succinylcholine does not worsen bupivacaine-induced cardiotoxicity in pentobarbital-anaesthetized dogs.

Authors:  J E de La Coussaye; B P Bassoul; B Albat; P A Peray; J P Gagnol; J J Eledjam; A Sassine
Journal:  Can J Anaesth       Date:  1992-02       Impact factor: 5.063

8.  The protective effect of lipid emulsion in preventing bupivacaine-induced mitochondrial injury and apoptosis of H9C2 cardiomyocytes.

Authors:  Zhe Chen; Zhousheng Jin; Yun Xia; Shishi Zhao; Xuzhong Xu; Thomas J Papadimos; Quanguang Wang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.